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AMPA receptors (AMPARs) conduct fast, excitatory currents that depolarize neurons and trigger
action potentials. AMPARs took on new importance when it was shown that AMPAR transport can
increase or decrease the number of AMPARs at synapses and give rise to synapse plasticity, includ-
ing long-term potentiation (LTP) and long-term depression (LTD). This review considers how trans-
membrane AMPAR regulatory proteins (TARPs), a novel family of AMPAR auxiliary subunits, have
changed our view of AMPAR transport and raised some perplexing questions.AMPARs are tetrameric combinations of subunits
GluR1–4 (GluRA–D) that are assembled in the ER and
transported through the Golgi apparatus to the plasma
membrane. Once they reach the cell surface, they may
travel to the synapse, where they anchor and commence
transmission. Initial studies of AMPAR transport identified
proteins that bind to the cytoplasmic, C-terminal domains
(CTDs) of the subunits and regulate trafficking (Barry and
Ziff, 2002). Compelling evidence (discussed below) soon
emerged that different AMPAR subunits bound different
trafficking proteins and obeyed different trafficking rules.
Indeed, when CTDs were exchanged between subunit
types, the trafficking properties of the resulting chimeras
also changed (Shi et al., 2001). This bolstered a ‘‘CTD-
centric’’ view of AMPAR trafficking control. However,
studies of an epileptic mouse, stargazer, soon showed
that mechanisms based on CTDs alone are far from com-
plete (for other recent reviews see Nicoll et al., 2006; Osten
and Stern-Bach, 2006).
Clues from the Stargazer Mouse
The stargazer mouse is a spontaneous mutant that dis-
plays absence epilepsy, head tossing, and ataxic gate
(Letts et al., 1998; Noebels et al., 1990). The stg locus
encodes a 38 kDa protein with four membrane-spanning
regions and cytosolic N and C termini. Because of its
homology to the non-pore forming, skeletal muscle
L-type Ca2+ channel subunit, g-1, the peptide was named
g-2, but it is more often called stargazin.
A breakthrough in understanding the stargazer pheno-
type came from two reports that provided evidence that
cerebellar mossy fiber to granule cell synapses of
stargazer, and the allelic waggler mouse, lack the fast,
AMPAR component of mini EPSCs, suggesting that these
synapses lack functional AMPAR (Chen et al., 1999;
Hashimoto et al., 1999). Indeed, stargazer granule cells
do not respond to bath-applied or pressure-ejected
AMPA, although NMDA receptor (NMDAR) responses
and the cellular levels of the AMPAR subunit proteins
and mRNAs are all close to normal. Because the AMPARcurrents in hippocampus were also normal, the stargazer
mutation appeared to eliminate functional AMPARs
selectively from the surface of cerebellar granule cells. In
a pivotal experiment, Chen and coworkers (Chen et al.,
2000) showed that stargazin forms a specific complex
with AMPAR subunits and also binds through its C termi-
nus to the synaptic scaffolding protein, PSD95. PSD95 is
a member of the MAGUK family of scaffolding proteins
and a component of the postsynaptic density (PSD), a
large protein complex that tethers NMDARs and other
peptides at the postsynaptic membrane (Ziff, 1997). In
a striking demonstration of stargazin’s role, Chen et al.
showed that expression of wild-type stargazin protein in
stargazer mutant granule cells restores both the AMPAR
mini EPSCs and the response to nonsynaptic glutamate
applied by pressure ejection. Because mini EPSCs are re-
sponses to synaptically released glutamate, this result
demonstrated that stargazin brings AMPARs to synapses.
Notably, stargazin lacking the PSD95 binding site (starga-
zinDC) did not restore the mini EPSCs, although it restored
the nonsynaptic currents. This indicated that functions of
stargazin that do not rely on PSD95 are sufficient for the
transport of AMPAR to the cell surface, and that synaptic
localization of the receptors relies on the interaction of the
stargazin C terminus with PSD95 (Figure 1). The stargazin
C terminus also interacts with PSD93, which is related to
PSD95 (Dakoji et al., 2003), and with another multi-PDZ
domain-containing protein, MAGI-2 (Deng et al., 2006),
potentially extending the number and types of anchor-
ages. Significantly, Ca2+ currents were unaffected in the
stargazer mouse, making disruption of Ca2+ channel func-
tion unlikely to be the primary stargazer defect (however,
see Letts, 2005).
Brain Region Expression of the TARP Family
Rodents express a family of eight stargazin-related pro-
teins (g-1 to g-8) and four of these, g-2, g-3, g-4, and g-8,
collectively called TARPs, have been implicated in AMPAR
function (Tomita et al., 2003; Yamazaki et al., 2004). The
TARPs resemble a class of membrane-spanning proteinsNeuron 53, March 1, 2007 ª2007 Elsevier Inc. 627
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(A) AMPARs are assembled in the ER by successive formation of dimers and tetramers. TARPs associate with AMPARs in the ER and generate an ER
export-competent receptor, possibly by facilitating assembly through association with subunit monomers or dimers (not shown), displacing an ER
retention factor, or by stabilizing an ER export-competent receptor conformation. See text. (B) After exiting the ER, the receptor-TARP complex
trafficks to the plasma membrane where it is inserted at an extrasynaptic site. The complex diffuses to the synapse, where interaction of the
TARP C-terminal PDZ binding site with the synaptic scaffolding protein PSD95 anchors the complex at the synapse. See text.with established cell junction functions, the tetraspanin
proteins, in that they have cytosolic termini and four mem-
brane-spanning regions (Tomita et al., 2003). However,
unlike the tetraspanins, the stargazin N-terminal extracel-
lular loop is larger than the C-terminal extracellular loop,
and stargazin lacks highly conserved homologies that
unite the classic tetraspanins (Hemler, 2003). Although
not true tetraspanins, the TARP four-helix structures
may yet be closely packed, as with the tetraspanins.
One or more of the TARPs are expressed in essentially
all brain regions, and some regions, such as hippocam-
pus, express more than one TARP (Tomita et al., 2003).
While g-2 is expressed in cortex, midbrain, hippocampus
(in both CA3 and dentate gyrus regions), pons, cerebel-
lum, and thalamus (Letts et al., 1998; Moss et al., 2003;
Sharp et al., 2001; Tomita et al., 2003), the related g-3
is expressed in cerebral cortex, and g-4 and g-8 are ex-
pressed in olfactory bulb and hippocampus, respectively.
Also, g-4 is expressed early in development and g-3 and
g-8 are expressed later.
How general is the requirement for TARPs? Although
cerebellar functions, such as eyeblink conditioning, are
impaired in stargazer mice, hippocampal functions are
normal. However, the normalcy of hippocampal function
in stargazer is most likely a result of gene complemen-
tation. Indeed, gene knockouts suggest a widespread de-
pendence of AMPARs on TARPs in brain. When the g-8
TARP, which is expressed in hippocampus, was knocked
out, hippocampal extrasynaptic AMPARs were severely
depleted and AMPAR subunit protein was overall greatly628 Neuron 53, March 1, 2007 ª2007 Elsevier Inc.decreased and limited to a small ER pool, a profound ef-
fect that also suggested subunit instability in the absence
of g-8 (Rouach et al., 2005). An enhancement of the syn-
aptic trafficking of the remaining receptors, perhaps by
g-2, appears to have limited the severity of the phenotype,
because much greater defects were seen in the g-2/g-8
double knockout. Furthermore, functional counterparts
of stargazin are expressed in C. elegans, Drosophila,
and Apis mellifera, suggesting an evolutionarily conserved
role (Walker et al., 2006).
Regulation of AMPAR ER Exit and the UPR
Stargazin appears to contribute to multiple AMPAR func-
tions, starting at the early stages of receptor biogenesis
with facilitating receptor export from the ER (Figure 1A).
AMPAR subunit tetramers are assembled in the ER, and,
as is true for many integral membrane protein complexes,
assembly is a prerequisite for export from the ER. Al-
though it is not yet firmly established where and when star-
gazin and the AMPAR first interact, FRET studies indicate
the two are in close proximity in the ER (Bedoukian et al.,
2006). Also, the immature glycosylation of AMPARs in
cerebellum of stargazer mice indicates that in the absence
of stargazin, the AMPARs are retained in the ER, and
suggests that efficient ER export of the receptor requires
stargazin (Tomita et al., 2003). Stargazin also affects
AMPARs in heterologous systems and can increase
expression of exogenous GluR1 on the surface of
COS7 cells. Significantly, stimulation of the unfolded
protein response (UPR) shows a similar enhancement
Neuron
MinireviewFigure 2. Domains and Interactions of AMPARs and TARPs
(A) (Left) An AMPAR subunit, including the N-terminal domain (NTD), the ligand binding domain (LBD), and the C-terminal domain (CTD). The LBD is
composed of the S1 and S2 regions, within which agonist (glutamate, yellow) binds. The functional AMPAR is tetrameric. (Right) A TARP, with cyto-
plasmic N and C termini and four membrane-spanning regions. The first extracellular loop is large and binds the AMPAR LBD at a region whose struc-
ture is flip or flop, dependent on splicing variation. The interaction modulates biophysical properties of the AMPAR. The CTD of the TARP binds to
PSD95 and mediates synaptic anchorage. Approximate locations of binding sites within the CTD for PSD95, nPIST, MAP1-LC2, and a phosphorylated
region are shown. The AMPAR cartoon is adapted from Gouaux, (2004). See text. (B) Image of an AMPAR complex determined by electron micros-
copy (reproduced from Nakagawa et al., 2006), indicating the positions within the receptor of: a dimer of N-terminal domains [(NTD)2], the LBDs, and
the transmembrane domains (TMD). The approximate region of density that stargazin contributes to a stargazin-AMPAR complex is indicated by
a dashed line. See Nakagawa et al. (2005) and text.(Vandenberghe et al., 2005a). The UPR is a response by
the ER to improperly folded proteins that increases ER
protein folding capacity. When the UPR is induced in
COS7 cells, either pharmacologically or by expression of
the UPR transcription factor p50ATF6, surface levels of
exogenous GluR1 are greatly increased, indicating that
protein folding is a limiting factor in GluR1 surface traffick-
ing in COS7. Interestingly, stargazin expression occluded
this effect, suggesting that stargazin and the UPR acted at
the same step. Indeed, the levels of the ER chaperone BiP
are increased in stargazer cerebellar cultures, indicating
that stargazer neurons have a defect in protein folding
(Schnell et al., 2002; Vandenberghe et al., 2005a).
Because the UPR could compensate for stargazin’s
absence, stargazin may accelerate, but not be strictly
required for, AMPAR assembly or transport to the cell sur-
face, at least in a heterologous system. The UPR results
raise the possibility that stargazin contributes to the
AMPAR assembly process. Indeed, AMPAR subunits
were greatly destabilized in hippocampus of the g-8
knockout (Rouach et al., 2005), as might be expected if
curtailed assembly allowed the subunits to degrade.
AMPAR subunit assembly is incompletely understood,
but it is thought to take place in two steps: (1) formation
of subunit dimers via interactions of subunit monomer N
termini, and (2) dimerization of dimers through interactions
of membrane-spanning regions and extracellular loops(Ayalon and Stern-Bach, 2001). Stargazin could enhance
assembly by facilitating subunit-subunit interaction during
assembly or by stabilizing assembly-competent confor-
mations of assembly intermediates.
Other results suggest a role for stargazin in escape from
ER retention. AMPAR subunits are expressed in flip and
flop splicing variants, which alter the structure of the
ligand binding domain (LBD) (Sommer et al., 1990) (Fig-
ure 2A). It is intriguing that in heterologous cells (which
lack TARPs), the flop isoform of the GluR4 (GluRD) subunit
is much less efficiently exported from the ER than the flip
isoform, and that coexpression of stargazin enhanced the
surface transport of the flop isoform of GluR4 nearly to the
level of flip. Notably, the deficit in flop transport could be
observed with the isolated LBD, which consists of a fusion
of the S1S2 fragments (Coleman et al., 2006). The S1S2
fusion construct lacks the membrane-spanning regions
of the subunits and is lumenal. Thus, the barrier for flop ex-
port may involve a lumenal ER retention factor. The critical
flop versus flip residue is located on an extracellular region
of the subunit surface, in an a-helix of the LBD, a region
that contacts the TARP first extracellular domain (see
below). Through its interaction with the receptor, stargazin
could mask an ER retention signal that predominately
affects the flop isoform. In addition to antagonizing a puta-
tive ER retention factor, stargazin could stabilize export-
competent conformations of the channel (Figure 1A).Neuron 53, March 1, 2007 ª2007 Elsevier Inc. 629
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agonist binding can profoundly limit ER export (Greger
et al., 2006), specific channel conformations that are re-
lated to the desensitized state appear to be approved by
the ER quality control machinery. Stargazin could stabilize
receptor conformational states competent for ER export.
Trafficking out of the Golgi
After leaving the ER, AMPARs travel through the Golgi
system and are inserted into the plasma membrane. Mi-
crotubule associated protein 1 light chain 2 (MAP1-LC2)
interacts with the stargazin C-tail, in GluR2 complexes,
upstream from the stargazin PDZ binding site (Figure 1B),
and could function in a microtubule-dependent receptor
trafficking step (Ives et al., 2004). Also, a stargazin C-tail
sequence that is required for synaptic clustering of
AMPAR binds to the protein nPIST. nPIST is enriched in
Golgi and dendritic tubulovesicles and in the PSD (Cuadra
et al., 2004), and may help AMPAR complexes leave the
Golgi and be targeted to the synapse.
Complexes of AMPARs with stargazinDC reach the
plasma membrane but not the synapse (Chen et al.,
2000). Thus, AMPAR-TARP complexes may be inserted
into the plasma membrane at extrasynaptic locations. Re-
cent studies of AMPAR diffusion in the plasma membrane
suggest that AMPARs are associated with stargazin at
both synaptic and extrasynaptic sites (Bats et al., 2007).
A dynamic interplay between the diffusing surface pop-
ulation of AMPAR-stargazin complexes and PSD95
anchorages determines the concentration of AMPAR at
postsynaptic sites. Because disruption of the PSD95-
stargazin interaction enhanced the diffusing population,
the interaction is likely to play an important role in trapping
diffusing receptors at the synapse (Figure 1B).
The precise mechanism of entry of AMPAR-TARP com-
plexes into the synapse and their capture and anchorage
by PSD95 is unknown, but may involve phosphorylation of
the TARP C-tails, which are between 100 and 200 aa long,
vary in length dependent on isoform, and are rich in serine
and threonine residues (Figure 2A). In vivo, the C-tail is
highly phosphorylated by CaMKII and PKC, and the level
of phosphorylation is especially high for stargazin that
is located in the PSD (Tomita et al., 2005b; Tsui and
Malenka, 2006). Because a phosphomimetic C-tail mutant
of stargazin enhanced AMPAR synaptic responses more
greatly than the wild-type, stargazin C-tail phosphoryla-
tion may promote AMPAR synaptic insertion. Strikingly,
NMDAR activation induced dephosphorylation of the
C-tail via PP1 (Tomita et al., 2005b). Because a phospho-
mimetic mutant that cannot be dephosphorylated blocked
LTD, LTD may result at least partially from stargazin C-tail
dephosphorylation under control of the NMDAR.
Auxiliary Subunit and Biophysical Functions
TARPS interact stably with AMPARs, and the TARPs may
be regarded as AMPAR auxiliary subunits. The contacts
TARPs make with AMPARs appear to be quite intimate
(Figure 2). Indeed, in the absence of stargazin, AMPARs630 Neuron 53, March 1, 2007 ª2007 Elsevier Inc.are more sensitive to proteolysis, suggesting that the star-
gazin association can shield the receptors from proteolytic
degradation in vitro (Vandenberghe et al., 2005b). The
TARP-AMPAR contacts may enable the TARPs to exert
a wide range of effects on AMPAR biophysical properties
(critically reviewed by Osten and Stern-Bach, 2006) by
stabilizing specific channel conformations or altering the
rate of transition between conformations. The biophysical
effects of stargazin depend primarily upon the first extra-
cellular loop, with some contribution from the C-tail (Priel
et al., 2005; Tomita et al., 2005a, 2006; Turetsky et al.,
2005). Analyses of chimeras of the g-5 TARP, which
does not promote either AMPAR trafficking or the gluta-
mate response, with g-2, which is biophysically active,
suggested that the first ectodomain loop controls the
peak amplitude and kinetics of AMPAR currents, possibly
through interactions with the subunit LBD (Figure 2A)
(Tomita et al., 2006). The LBD is a clamshell-like structure
that closes around the agonist and allosterically transmits
the effects to transmembrane helices of the pore, leading
to channel opening (Gouaux, 2004), and thus is a logical
target for regulating channel activation properties. Indeed,
stargazin slowed receptor desensitization (Priel et al.,
2005; Turetsky et al., 2005; Tomita et al., 2006), a rear-
rangement of the LBDs that allows the pore to close while
glutamate is still bound (Gouaux, 2004). A GluR2 mutation
that stabilizes the interface between two LBDs and blocks
desensitization (L483Y) occludes the current-enhancing
effects of stargazin (Priel et al., 2005; Tomita et al.,
2006). Thus, stargazin may enhance currents by shifting
the equilibrium away from desensitized conformations
toward the open state (Turetsky et al., 2005). Stargazin
also slows deactivation, an unbinding of glutamate that
closes the channel, possibly by increasing channel affinity
for agonist (Priel et al., 2005). Stargazin also prolongs
channel bursts (Tomita et al., 2005a) suggesting that it
may facilitate the glutamate-induced conformational
change of the LBD that opens the channel. In heterolo-
gous systems, stargazin appears to alter the biophysical
properties of AMPARs so that they more closely resemble
those of endogenous receptors, suggesting that stargazin
dictates these properties in vivo. Through these effects,
stargazin may increase the capacity of AMPARs to drive
physiologic functions of neurons.
The two major roles of TARPs, enhancing biophysical
properties and facilitating trafficking from the ER and
anchorage at the synapse, appear to be substantially
independent of one another, with the first extracellular
TARP loop modulating biophysical properties via contacts
with the LBD, and the TARP CTD mediating synaptic an-
chorage. However, the apparent role of the TARP-LBD
interaction in a lumenal mechanism of ER export, noted
above, suggests that the TARP first extracellular loop
functions in trafficking as well as in biophysical modula-
tion. Interestingly, the tetraspanins also associate with
a wide variety of transmembrane proteins though their
large extracellular loop (which is, however, their C-termi-
nal loop, EC2) (Hemler, 2003).
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Phosphorylation of the stargazin carboxylate terminus by
PKA blocks both stargazin binding to a PSD95 PDZ do-
main and stargazin coclustering with PSD95 (Chetkovich
et al., 2002; Choi et al., 2002). Although PKA phosphoryla-
tion and the subsequent unbinding of stargazin from
PSD95 provide an attractive mechanism for the release
of AMPARs from synapses, such regulation has not yet
been observed in vivo. Interestingly, glutamate itself may
regulate synaptic complexes, specifically complexes of
AMPAR with TARPs. AMPA stimulation of g-3-AMPAR
complexes in neurons induced the endocytosis of the
AMPAR, but not the endocytosis of the g-3 TARP,
suggesting that binding of an agonist can dissociate the
AMPAR from the TARP (Tomita et al., 2004; but see
Nakagawa et al., 2005). The dissociation of detergent-
solubilized AMPAR-stargazin complexes by AMPA was
observed and was blocked by AMPAR antagonists, but
not by cyclothiazide, a blocker of receptor desensitization.
This suggests that conformational changes associated
with agonist binding, rather than the subsequent receptor
desensitization, may release the receptor from the TARP.
Specific TARP Complexes with AMPARs
Given the wide variety of ways in which TARPs influence
AMPARs, a number of labs have focused on identifying
specific TARP-AMPAR complexes. AMPARs are released
from cerebellar lysate by detergents as large complexes.
Two of these with Mr greater than 700 kDa, when resolved
on native gels, were found to contain GluR2/3. The slower
migrating complex was absent from stargazer mutant ex-
tracts (Vandenberghe et al., 2005b), consistent with it be-
ing an AMPAR-stargazin complex. AMPAR complexes
with other AMPAR binding proteins, including ABP/
GRIP, NSF, and PICK1 (see discussion below), were not
detected in this study, which suggested that stargazin-
AMPAR complexes were the primary AMPAR form that
could be solubilized by detergents. Undoubtedly, the
types of complexes that can be extracted reflect the ex-
traction conditions as well as the nature of the interactions
that maintain the complexes. Significantly, others have
reported abundant AMPAR-GRIP complexes in brain
(Wyszynski et al., 1999).
Single-particle electron microscopy has given a view of
the 3D structure of the AMPAR tetramer and has revealed
the topology of the contribution by TARPs (Nakagawa
et al., 2005; Nakagawa et al., 2006). In these images of
the tetrameric channel (Figure 2B), two dimers of N-termi-
nal domains are seen, clearly separated from one another.
Each NTD dimer joins to an LBD dimer that fuses with the
tetrameric membrane-spanning region complex. TARPs
widen the density of the membrane-spanning region in
these images, which is as expected if the TARPs dock in
the membrane adjacent to the receptor. Major features
of the complex remain, however, unestablished, in partic-
ular, the stoichiometry. If AMPARs are regarded as dimers
of dimers (Gouaux, 2004), a single TARP could associate
with each dimer at the dimer-subunit junction, leading toa ratio of two TARPs per AMPAR. Alternatively, each sub-
unit could bind its own TARP, whereupon the stoichiome-
try would be four TARPs per AMPAR.
The Trafficking Paradox: Which Regulates
AMPARs—Subunit Tails or TARPs?
From the foregoing, it appears that stargazin is involved in
nearly every step in the life of AMPAR, from biogenesis to
physiologic function to synaptic response. Thus, it is dis-
concerting that each of these steps has also been shown
to depend on functions of peptides that bind to the
AMPAR subunits’ own C termini, including GRIP/ABP,
PICK1, NSF, and SAP97 (Barry and Ziff, 2002). The func-
tional relationships of these CTD binding factors to the
TARPs are unexplored. The paradox is most evident if
one considers that several established features of AMPAR
plasticity are subunit specific and are dictated by the sub-
unit CTDs. The CTDs fall into two types: the long CTDs of
GluR1, GluR2L, and GluR4; and the short CTDs of GluR2
and GluR3. Properties of long CTD subunits, including de-
pendence of synaptic insertion upon neuron activation,
are dominant in heterotetramers containing both long
and short CTD subunits, and as noted, switching the
CTDs switches the properties (Shi et al., 2001). Further-
more, only heteromers containing exclusively short CTD
subunits (i.e., GluR2/3 heteromers) do not require activity
for synapse insertion. Molecular mechanisms accounting
for these and other forms of C-tail-dependent subunit traf-
ficking specificity have been described (reviewed by Barry
and Ziff, 2002). Surface insertion of GluR1 depends on
serine 845 phosphorylation within the CTD (Roche et al.,
1996; Oh et al., 2006; Esteban et al., 2003). Of particular
relevance, entry of extrasynaptic GluR1 into synapses de-
pends on phosphorylation of serine 816 (Boehm et al.,
2006). The GluR2 PDZ binding site tethers AMPARs at
GRIP/ABP anchorages and AMPARs are released by ser-
ine 880 phosphorylation in the CTD. Subsequent receptor
association with PICK1 can lead to receptor endocytosis
or exocytosis, depending on the system (Chung et al.,
2000; Gardner et al., 2005; Liu and Cull-Candy, 2005; Lu
and Ziff, 2005; Terashima et al., 2004; Xia et al., 2000).
These and other CTD trafficking steps provide great
versatility in converting activity-dependent signals into
subunit-specific trafficking. Nonetheless, in receptor sur-
face diffusion studies, the PSD95-stargazin interaction
was paramount for receptor synaptic trapping, and dele-
tion of the GluR2 PDZ binding site within the C-tail had
no effect (Bats et al., 2007). The question is, how can traf-
ficking and anchorage properties of AMPARs be highly
subunit C-tail specific but also strongly reliant on TARPs,
especially when TARP functions lack apparent subunit
specificity (but see Turetsky et al., 2005)?
The simplest solution to this paradox is that the CTD
binding proteins act upon AMPAR-TARP complexes. Per-
haps TARPs provide generalized functions, such as the
facilitation of exit from the ER, while CTD binding proteins
confer subunit specificity on the subsequent trafficking.
Alternatively, TARPs may contribute to synaptogenesisNeuron 53, March 1, 2007 ª2007 Elsevier Inc. 631
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early-development MAGUK scaffolding proteins such as
SAP102 (Elias et al., 2006) to anchor TARP-AMPAR com-
plexes at synapses. MAGUKs, including PSD95, anchor
NMDARs prior to the transport of AMPARs to synapses
(reviewed by Perez-Otano and Ehlers, 2004). Through
their interaction with SAP102, PSD95, or other MAGUKs,
via stargazin, AMPARs may share a scaffold with
NMDARs. In the special case of cultured ventral spinal
neurons, AMPARs, stargazin, and a PSD95-related factor
may cooperate to target NMDARs to synapses, rather
than the reverse, giving precedence to AMPARs in this
mechanism (Mi et al., 2004). Later in development, other
subunit-specific scaffolds, such as GRIP/ABP, may be in-
stalled to accommodate subunit-specific trafficking. A
third possibility is that AMPARs shed the TARPs when
they bind glutamate, and the CTD factors then take control
of trafficking. In yet another scenario, certain splice variant
isoforms of the receptor subunits (flip versus flop) could
have decreased reliance on TARPs, and may exit from
the ER on their own, eventually to be guided in their traf-
ficking by CTD binding proteins. In any event, the traffick-
ing and anchorage mechanisms provided by the TARPs
and subunit CTD binding proteins are likely to be related.
For example, both sets of proteins utilize phosphorylation
of the cytoplasmic CTD to control trafficking. In this view,
the TARPs may dictate the initial trafficking and biophysi-
cal properties of the receptor after synthesis or in early de-
velopment, while subunit CTD binding proteins refine
these properties by imparting subunit-specific trafficking
in response to specialized features of neuron activity or
biochemical stimulation.
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